ALNY logo
ALNY

Alnylam Pharmaceuticals Inc

Biotechnology

Alnylam Pharmaceuticals Inc (ALNY) Earnings

Last reported
April 30, 2026
EPS estimate
$0.97
EPS actual
Revenue est.
$1.1B
Revenue actual